1. Ghafouri-Fard, Soudeh, Khoshbakht, Tayyebeh, Taheri, Mohammad, Shojaei, Seyedpouzhia. 2022. A Review on the Role of SPRY4-IT1 in the Carcinogenesis. In Frontiers in oncology, 11, 779483. doi:10.3389/fonc.2021.779483. https://pubmed.ncbi.nlm.nih.gov/35096580/
2. Marques, Inês J, Gomes, Inês, Pojo, Marta, Leite, Valeriano, Cavaco, Branca M. 2021. Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer. In Thyroid : official journal of the American Thyroid Association, 31, 1366-1375. doi:10.1089/thy.2020.0290. https://pubmed.ncbi.nlm.nih.gov/33906393/
3. Sarkar, Debina, Leung, Euphemia Y, Baguley, Bruce C, Finlay, Graeme J, Askarian-Amiri, Marjan E. . Epigenetic regulation in human melanoma: past and future. In Epigenetics, 10, 103-21. doi:10.1080/15592294.2014.1003746. https://pubmed.ncbi.nlm.nih.gov/25587943/
4. Miraoui, Hichem, Dwyer, Andrew A, Sykiotis, Gerasimos P, Lage, Kasper, Pitteloud, Nelly. . Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. In American journal of human genetics, 92, 725-43. doi:10.1016/j.ajhg.2013.04.008. https://pubmed.ncbi.nlm.nih.gov/23643382/
5. Xia, Lingjin, Huang, Jiami, Che, Qi, Liu, Suying, Du, Jing. . A heterozygous SPRY4 variant identified in female infertility characterized by reduced oocyte potential and early embryonic arrest. In Human reproduction (Oxford, England), 39, 2618-2629. doi:10.1093/humrep/deae231. https://pubmed.ncbi.nlm.nih.gov/39348320/
6. Huang, Chen, Wang, Ming, Zhao, Wen-Yi, Tu, Lin, Cao, Hui. 2023. Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1. In American journal of translational research, 15, 1026-1040. doi:. https://pubmed.ncbi.nlm.nih.gov/36915750/